REG - Clontarf Energy PLC - Issue of Share Options

Clontarf EnergyAnnouncement

02/10/2019 16:00

RNS Number : 5514O
Clontarf Energy PLC
02 October 2019
 


                                                                                                                                                                                               
2nd October 2019
 




Clontarf Energy plc
("Clontarf" or "the Company")
 
Issue of Share Options
 
The board of Clontarf Energy plc announces that Directors John Teeling, David Horgan, Jim Finn and Peter O'Toole have each been granted options over 10,000,000 ordinary shares of 0.25 pence in the Company ("the Options").  The Options vest in equal tranches over a three year period commencing from the date of grant, have an exercise price is 0.7 pence and an expiry date of 1 October 2026.
 
Accordingly, as at today's date, a total of 40,000,000 options are outstanding, accounting for approximately 5.6 per cent. of the Company's currently issued share capital.
 
 
This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.
 
Ends
 
 
For further information please visit http://clontarfenergy.com or contact:
 



Clontarf Energy
John Teeling, Chairman
David Horgan, Director


+353 (0) 1 833 2833














Nominated & Financial Adviser
Strand Hanson Limited
Rory Murphy
Ritchie Balmer
Georgia Langoulant


+44 (0) 20 7409 3494














Broker
Novum Securities Limited
Colin Rowbury


        +44 (0) 207 399 9400














Public Relations
Blytheweigh
Julia Tilley
Fergus Cowan


 
+44 (0) 207 138 3206
+44 (0) 207 138 3553
+44 (0) 207 138 3208














Teneo
Luke Hogg
Alan Tyrrell


+353 (0) 1 661 4055
+353 (0) 1 661 4055



 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOECKBDNNBDDFKK